Revolutionary Immunotherapies and Targeted Treatments Propel Cancer Survival to Historic 70%, Yet Deep Disparities Persist Across the United States
The American Cancer Society’s Cancer Statistics 2026 report unveils a compelling narrative of scientific triumph,...
